These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21242470)

  • 1. Prevalence of toenail onychomycosis in patients with type 2 diabetes mellitus and evaluation of risk factors.
    Gulcan A; Gulcan E; Oksuz S; Sahin I; Kaya D
    J Am Podiatr Med Assoc; 2011; 101(1):49-54. PubMed ID: 21242470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Onychomycosis by yeast not common in diabetics of a health center].
    Imbert JL; G Gomez JV; Escudero RB; Blasco JL
    Semergen; 2016 Oct; 42(7):449-457. PubMed ID: 26482238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toenail onychomycosis in Estonia.
    Järv H; Naaber P; Kaur S; Eisen M; Silm H
    Mycoses; 2004 Feb; 47(1-2):57-61. PubMed ID: 14998401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001.
    Ioannidou DJ; Maraki S; Krasagakis SK; Tosca A; Tselentis Y
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):170-4. PubMed ID: 16441625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations.
    Gupta AK; Daigle D; Foley KA
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1039-44. PubMed ID: 25413984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal foot infections in patients with diabetes mellitus--results of two independent investigations.
    Eckhard M; Lengler A; Liersch J; Bretzel RG; Mayser P
    Mycoses; 2007; 50 Suppl 2():14-9. PubMed ID: 17681049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada--a multicenter survey of 2001 patients.
    Gupta AK; Jain HC; Lynde CW; Watteel GN; Summerbell RC
    Int J Dermatol; 1997 Oct; 36(10):783-7. PubMed ID: 9372358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and mycologic characteristics of onychomycosis in diabetic patients.
    Al-Mutairi N; Eassa BI; Al-Rqobah DA
    Acta Dermatovenerol Croat; 2010; 18(2):84-91. PubMed ID: 20624357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onychomycosis in Adana, Turkey: a 5-year study.
    Ilkit M
    Int J Dermatol; 2005 Oct; 44(10):851-4. PubMed ID: 16207188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of toe nail onychomycosis in diabetic patients.
    Saunte DM; Holgersen JB; Haedersdal M; Strauss G; Bitsch M; Svendsen OL; Arendrup MC; Svejgaard EL
    Acta Derm Venereol; 2006; 86(5):425-8. PubMed ID: 16955188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onychomycosis in Denmark: prevalence of fungal nail infection in general practice.
    Svejgaard EL; Nilsson J
    Mycoses; 2004 Apr; 47(3-4):131-5. PubMed ID: 15078429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, Risk Factors, and Type of Organism in Fungal Foot Infection and Toenail Onychomycosis in Thai Diabetic Patients.
    Assadamongkol R; Lertwattanarak R; Wannachalee T; Bunyaratavej S; Leeyaphan C; Matthapan L
    J Med Assoc Thai; 2016 Jun; 99(6):659-64. PubMed ID: 29900728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Onychomycosis in Casablanca (Morocco)].
    Halim I; El Kadioui F; Soussi Abdallaoui M
    J Mycol Med; 2013 Mar; 23(1):9-14. PubMed ID: 23287730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Onychomycosis: multicentre epidemiological, clinical and mycological study].
    Relloso S; Arechavala A; Guelfand L; Maldonado I; Walker L; Agorio I; Reyes S; Giusiano G; Rojas F; Flores V; Capece P; Posse G; Nicola F; Tutzer S; Bianchi M
    Rev Iberoam Micol; 2012; 29(3):157-63. PubMed ID: 22198612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Causative agents of onychomycosis--a retrospective study].
    Mügge C; Haustein UF; Nenoff P
    J Dtsch Dermatol Ges; 2006 Mar; 4(3):218-28. PubMed ID: 16626318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toenail onychomycosis in diabetic patients: issues and management.
    Mayser P; Freund V; Budihardja D
    Am J Clin Dermatol; 2009; 10(4):211-20. PubMed ID: 19489654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns.
    Eba M; Njunda AL; Mouliom RN; Kwenti ET; Fuh AN; Nchanji GT; Atashili J
    BMC Res Notes; 2016 Nov; 9(1):494. PubMed ID: 27876085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onychomycosis in Diabetics: Prevalence, Clinical Features and Spectrum of Causative Fungi in South-Eastern Nigeria.
    Anyanechi CN; Ojinmah UR; Anyanechi CC; Nnaji TO; Ozoh GA
    West Afr J Med; 2024 Apr; 41(4):363-371. PubMed ID: 39002161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence of onychomycosis among psoriatic patients in Israel.
    Leibovici V; Hershko K; Ingber A; Westerman M; Leviatan-Strauss N; Hochberg M
    Acta Derm Venereol; 2008; 88(1):31-3. PubMed ID: 18176747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aetiology of onychomycosis in Al Ain, United Arab Emirates.
    Nsanze H; Lestringant GG; Mustafa N; Usmani MA
    Mycoses; 1995; 38(9-10):421-4. PubMed ID: 8569820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.